Liu, Yuanqing https://orcid.org/0009-0008-7445-8467
Wang, Shasha
Chen, Yanni
Zhang, Zhang
Quan, Xiaojiang
Guo, Zhijun
Wang, Zihao
Article History
Received: 9 December 2024
Revised: 29 May 2025
Accepted: 25 June 2025
First Online: 3 July 2025
Competing interests
: All authors are employees of Immorna Biotechnology/Immorna Biotherapeutics. Z.W., Y. L., and Z. G. are inventors to the Chinese patent CN118903476B.
: All animal experiments were performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals and relevant Chinese laws and regulations. All animal use adhered to the IACUC guidelines for animal ethics and welfare. The in vivo experiment protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai Jiaotong University, China (authorization number: A2022044), and Shanghai Model Organisms Center, Inc., China (authorization number: No. 2020-0047).